Orphenadrine (CAS 61825-94-3) Market Research Report 2026

June 2026 | 50 pages | ID: O134DA2C962EN
BAC Reports

Abstracts

Orphenadrine (CAS 61825-94-3) Market Research Report 2026 presents comprehensive data on Orphenadrine markets globally and regionally (Europe, Asia, North America etc.)

The report includes Orphenadrine description, covers its application areas and related patterns. It overviews Orphenadrine market, names Orphenadrine producers and indicates its suppliers.

Besides, the report provides Orphenadrine prices in regional markets.

In addition to the above the report determines Orphenadrine consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

• capacities and production
• consumption volume and structure
• market price trends
• exports and imports
• existing technologies
• feedstock market condition
• market news digest
• market forecast.

Orphenadrine (CAS 61825-94-3) Market Research Report 2026 can feature:

• market condition and estimations, market forecast
• chemical product ranges, trademarks, analogous products, application areas
• regional and global producers, consumers and traders (including contact details).

Contents

1. ORPHENADRINE (CAS 61825-94-3)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. ORPHENADRINE APPLICATIONS

2.1. Orphenadrine application spheres, downstream products

3. ORPHENADRINE MANUFACTURING METHODS

4. ORPHENADRINE PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. ORPHENADRINE MARKET WORLDWIDE 

5.1. General Orphenadrine market situation, trends
5.2. Manufacturers of Orphenadrine
- Europe
- Asia
- North America
- Other regions
5.3. Orphenadrine suppliers (importers, local distributors)
- Europe
- Asia
- North America
- Other regions
5.4. Orphenadrine market forecast

6. ORPHENADRINE MARKET PRICES

6.1. Orphenadrine prices in Europe
6.2. Orphenadrine prices in Asia
6.3. Orphenadrine prices in North America
6.4. Orphenadrine prices in other regions

7. ORPHENADRINE END-USE SECTOR 

7.1. Orphenadrine market by application sphere
7.2. Orphenadrine downstream markets trends and prospects

*Please note that Orphenadrine (CAS 61825-94-3) Market Research Report 2026 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 5-7 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 5-7 days to update a report after an order is received.

About

Product Name:	Orphenadrine
Synonyms:	Oxaliplatin OXALIPLATIN Oxaliplatin(DMF)and its intermediates Oxaliplatin (JAN/USAN) (1R-trans)-(1,2-Cyclohexanediamine-N,N')-(ethanedionato(2-)-O,O')-platinum Oxalato-(1R,2R-cyclohexanediamine)-platinum(II) Oxalatoplatin [(1R,2R)-1,2-Cyclohexanediamine-N,N'][oxalato(2-)-O,O']-platinum
CAS#:	61825-94-3
Formula:	C8H14N2O4Pt
Molecular Weight:	397.29

Oxaliplatin (oxalate, Oxalatoplatin, Oxalatoplatinum, Eloxatin, Eloxatin (TN)) is a platinum-based chemotherapy drug that refers to the same family as cisplatin and carboplatin. Oxaliplatin is a white solid with the molecular formula C8H14N2O4Pt and the molecular weight 397.29. The drug is slightly soluble in water, very slightly soluble in methanol and almost insoluble in 100% ethanol.

Oxaliplatin is an anti-neoplastic agent that is considered to form inter- and intrastrand DNA adducts. These adducts activate signaling pathways culminating in apoptosis. The efficient progenitor of oxaliplatin is cisplatin. At present, oxaliplatin displays higher cytotoxicity and lower nephrotoxicity than cisplatin, and demonstrates antitumor activity in cell lines with acquired cisplatin resistance. Oxaliplatin is used with other drugs to treat colorectal cancer and is also utilized as adjuvant therapy in patients who have had surgery to remove the cancer. Moreover, the product is used in the preparation of oxaliplatin-based combinations (cytotoxic therapeutic agents).

Oxaliplatin may cause eye irritation and damage in some persons. The product can produce health damage following entry through wounds, lesions or abrasions. Loss of appetite, nausea, vomiting, skin rash, redness, low blood pressure, unwellness, anaphylactic shock, gout and renal failure are amid acute side effects of oxaliplatin. The product also causes inflammation of the mouth cavity, mouth ulcers, oesophagus inflammation, abdominal pain and bleeds, diarrhoea, bowel ulcers and perforation.

Oxaliplatin market is covered in the study OXALIPLATIN (CAS 61825-94-3) Market Research Report 2013. The report encompasses proper description of the product, unveils application areas, and briefly summarizes patents in the sphere. It overlooks oxaliplatin market situation, names manufacturers, suppliers as well as users. The report also provides current oxaliplatin prices in the market.